These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9854473)

  • 1. Serum hepatocyte growth factor level associate with gastric cancer progression.
    Wu CW; Chi CW; Su TL; Liu TY; Lui WY; P'eng FK
    Anticancer Res; 1998; 18(5B):3657-9. PubMed ID: 9854473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue.
    Beppu K; Uchiyama A; Morisaki T; Nakamura K; Noshiro H; Matsumoto K; Nakamura T; Tanaka M; Katano M
    Anticancer Res; 2000; 20(2B):1263-7. PubMed ID: 10810432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma.
    Tanaka K; Miki C; Wakuda R; Kobayashi M; Tonouchi H; Kusunoki M
    Scand J Gastroenterol; 2004 Aug; 39(8):754-60. PubMed ID: 15513361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum human hepatocyte growth factor (hHGF) is elevated in patients with metastatic gastric carcinoma.
    Niki M; Isozaki H; Toyoda M; Ishibashi T; Fujii K; Nomura E; Mabuchi H; Nakamura M; Nishiguchi K; Tanigawa N
    Hepatogastroenterology; 1999; 46(25):568-73. PubMed ID: 10228863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer.
    Yasuda K; Nagakawa O; Akashi T; Fujiuchi Y; Koizumi K; Komiya A; Saiki I; Fuse H
    Prostate; 2009 Mar; 69(4):346-51. PubMed ID: 19021204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum human hepatocyte growth factor (hHGF) is elevated in patients with metastatic gastric carcinoma.
    Niki M; Isozaki H; Toyoda M; Ishibashi T; Fujii K; Nomura E; Mabuchi H; Nakamura M; Nishiguchi K; Tanigawa N
    Hepatogastroenterology; 1998; 45(24):2458-63. PubMed ID: 9951944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [mRNA expression of IGF-IIand HGF in relation to microvascular density, tumor progression and prognosis of gastric carcinoma].
    Zhao ZS; Ru GQ; Ma J
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):673-7. PubMed ID: 15777506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of hepatocyte growth factor in patients with breast cancer.
    Sheen-Chen SM; Liu YW; Eng HL; Chou FF
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):715-7. PubMed ID: 15767355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
    D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
    Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [mRNA expression of basic fibroblast growth factor and hepatocyte growth factor in gastric carcinoma and significance thereof].
    Ru GQ; Zhao ZS; Tang QL; Xu WJ
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2030-5. PubMed ID: 19080429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of hepatocyte growth factor and basic fibroblast growth factor as prognostic indicators in gastric cancer.
    Zhang W; Chu YQ; Ye ZY; Zhao ZS; Tao HQ
    Anat Rec (Hoboken); 2009 Aug; 292(8):1114-21. PubMed ID: 19533745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined measurement of hepatocyte growth factor and carcinoembryonic antigen as a prognostic marker for patients with dukes a and B colorectal cancer: results of a five-year study.
    Miki C; Inoue Y; Hiro J; Ojima E; Araki T; Uchida K; Kusunoki M
    Dis Colon Rectum; 2006 Nov; 49(11):1710-8. PubMed ID: 16990975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum progesterone levels in patients with gastric adenocarcinoma before and after gastrectomy.
    Wu CW; Chi CW; Hsieh MC; Lo SS; Shen KH; Lui WY; P'eng FK
    Cancer; 1998 Aug; 83(3):445-8. PubMed ID: 9690536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between anti-tumor effects and serum hepatocyte growth factor level in patients with liver metastases from gastric cancer treated by induced hypertensive chemotherapy with angiotensin II].
    Iwasaki Y; Kitamura M; Arai K
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1874-7. PubMed ID: 9382555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of transforming growth factor beta1 are significantly correlated with venous invasion in patients with gastric cancer.
    Lin Y; Kikuchi S; Obata Y; Yagyu K;
    J Gastroenterol Hepatol; 2006 Feb; 21(2):432-7. PubMed ID: 16509870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.
    Park DJ; Yoon C; Thomas N; Ku GY; Janjigian YY; Kelsen DP; Ilson DH; Goodman KA; Tang LH; Strong VE; Coit DG; Yoon SS
    Ann Surg Oncol; 2014 Apr; 21(4):1130-7. PubMed ID: 24370903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between serum hepatocyte growth factor and survival in untreated hepatocellular carcinoma.
    Vejchapipat P; Tangkijvanich P; Theamboonlers A; Chongsrisawat V; Chittmittrapap S; Poovorawan Y
    J Gastroenterol; 2004 Dec; 39(12):1182-8. PubMed ID: 15622483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization and significance for prognosis of free gastric cancer cells in the peritoneal cavity.
    Li C; Ma Y; Xue Y; Zhang H; Wei Y
    Hepatogastroenterology; 2009; 56(91-92):891-8. PubMed ID: 19621724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
    Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW
    Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.